Brief: Better Therapeutics Receives FDA Breakthrough Device Designation For Digital Therapeutic Platform
20/02/2024 14:38
Feb 20 (Reuters) - Better Therapeutics Inc BTTX.O :
* BETTER THERAPEUTICS RECEIVES FDA BREAKTHROUGH DEVICE
DESIGNATION
FOR DIGITAL THERAPEUTIC PLATFORM TARGETING ADVANCED LIVER
DISEASE
Source text for Eikon: ID:nBw9SknRda
Further company coverage: BTTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Better Therapeutics
See all newsU.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
U.S. STOCKS ON THE MOVE-G-III Apparel Group, Tesla, MicroStrategy